Point Out Statins' CV Benefits STILL Outweigh Diabetes Risk
September 2014
You'll hear more about higher doses of statins increasing diabetes risk...partly due to reports of lawsuits in the lay press.
Help put this into perspective for patients.
Explain that statins' CV benefits STILL outweigh diabetes risk.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber Insights: APRN includes:
- Cutting-edge advice about new medications and how they fit into practice
- Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
- Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations
Already a subscriber? Log in
Volume pricing available. Get a quote